Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
02 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/health-canada-approves-agamree-vamorolone-as-the-first-treatment-for-duchenne-muscular-dystrophy-in-canada-302571841.html
06 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kye-pharmaceuticals-announces-the-approval-of-dyanavel-xr-amphetamine-extended-release-tablets-and-oral-suspension-for-the-treatment-of-adults-and-children-with-adhd-302519894.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057585/13009/en/Catalyst-Pharmaceuticals-Announces-Health-Canada-s-Acceptance-of-AGAMREE-New-Drug-Submission-with-Priority-Review-for-Sub-Licensee-Kye-Pharmaceuticals.html
11 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/11/2401826/13009/en/Catalyst-Pharmaceuticals-and-KYE-Pharmaceuticals-Announce-a-Second-Favorable-Canadian-Federal-Court-Ruling-Setting-Aside-Approval-of-Ruzurgi.html
05 Jan 2021
// NEWSWIRE
https://www.newswire.ca/news-releases/kye-pharmaceuticals-announces-approval-of-corzyna-tm-in-canada-ranolazine-extended-release-tablets--857098552.html#:~:text=(%22KYE%22)%2C%20a,Canada%20after%20a%20positive%20expedited
ABOUT THIS PAGE